Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable - S&P Global Ratings’ Credit Research

Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable

Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable - S&P Global Ratings’ Credit Research
Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable
Published Apr 16, 2026
3 pages (1303 words) — Published Apr 16, 2026
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

S&P Global Ratings assigned its 'A+' long-term rating to the Indiana Finance Authority ?s $286.1 million series 2026A revenue bonds, issued for Parkview Health , Ind. (Parkview). At the same time, we affirmed our 'A+' long-term and underlying (SPUR) ratings on Parkview Health System Obligated Group , Ind.'s debt outstanding issued by the Indiana Finance Authority and on the series 2020A taxable bonds issued by Parkview. Finally, we affirmed our 'AA+/A-1' dual rating on the authority's series 2009B, 2009C, and 2009D bonds (assuming low correlation) issued for Parkview. The outlook, where applicable, is stable. LANSING (S&P Global Ratings) April 16, 2026—S&P Global Ratings today took the rating actions listed above. We view Parkview's social factors as neutral in our credit

  
Brief Excerpt:

...S&P Global Ratings assigned its 'A+' long-term rating to the Indiana Finance Authority's $286.1 million series 2026A revenue bonds, issued for Parkview Health, Ind. (Parkview)....

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable" Apr 16, 2026. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Parkview-Health-IN-Series-2026A-Revenue-Bonds-Assigned-A-Rating-Outlook-Stable-3547286>
  
APA:
S&P Global Ratings’ Credit Research. (). Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable Apr 16, 2026. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Parkview-Health-IN-Series-2026A-Revenue-Bonds-Assigned-A-Rating-Outlook-Stable-3547286>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.